It seems that you have made a short term trading decision based on the events of last year (covid hype, FDA CRL, ARDS trial halt and CHF/CLBP trials not hitting the primary endpoint). Many traders who were looking for a quick gain on the GVHD decision lost out.
Most people here have made a long term investment decision to invest in MSB based on the fact that they do believe that MSB will get multiple treatments approved (currently COVID-19 ARDS, aGVHD, CHF, CLBP). I don't think you can deny that there is huge potential here, not without risk of course.
It seems that you have made a short term trading decision based...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.040(3.88%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.09 | $1.03 | $4.794M | 4.490M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 40 | 99002 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 11538 | 20 |
View Market Depth
| Last trade - 14.52pm 02/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |